-
Mashup Score: 6Monthly Plenary Series - 1 year(s) ago
The ASCO Plenary Series is a monthly online forum for presentation and discussion of the latest cancer research that keeps clinicians current on new and emerging research in between meetings. The Plenary Series provides faster dissemination of practice-changing science to better help clinicians deliver the most up-to-date care and treatments to patients with cancer. Each monthly program features…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Health Equity - 1 year(s) ago
Watch the ASCO 2023 Annual Meeting Patient Forum Featured Health Equity Article Lung Cancer Screening: Implementation Challenges and Health Equity Considerations for the Western Pacific Region As part of the Special Series “Cancer Care in the Asia Pacific,” this article explores the challenges to implementing lung cancer screening in the Western Pacific Region. By Claire Nightingale et…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
Creating an inclusive environment for people with #cancer starts with the first intake forms. Advocate Tony Christon-Walker shared how providers can show patients their office is welcoming and safe for #LGBTQ people. Hear more at: https://t.co/YDXnjRVOtf #ASCOHealthEquity https://t.co/gjsHpbtw7r
-
-
Mashup Score: 0Funding Opportunities - 1 year(s) ago
Our grants and awards support clinical and translational cancer research done by gifted physician-scientists at every stage of their careers, from the best and brightest among young investigators to senior researchers providing mentorship opportunities for the next generation of cancer researchers. For inquiries regarding Conquer Cancer funding opportunities, please contact our Grants team. For a…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
#bcsm #OncTwitter #DEI 📢 Funding opportunities from @ConquerCancerFd for trainee, early career, & mid-career #breastcancer investigators: https://t.co/AhwTmochYz. Application resources here: https://t.co/576CX5Rb6R. https://t.co/idIvVR6VG5
-
-
Mashup Score: 1International Development & Education Award - 1 year(s) ago
The International Development and Education Award (IDEA) provides support for early-career oncologists in low- and middle-income countries and facilitates the sharing of knowledge between these oncologists and members. The program pairs IDEA Recipients with a leading member “Mentor”, enables Recipients to attend the ASCO Annual Meeting, participate in a post-Meeting visit to their Mentor’s…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
The @ConquerCancerFd-supported International Development and Education Award (IDEA) empowers early-career members in #LMICs to make significant impact in their communities. @ce_okereke & @Drkrithika_rao share more. Submit your IDEA application by 10/2! https://t.co/JgrbWN1iP0 https://t.co/xZrhexCWVA
-
-
Mashup Score: 5Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
‼️ New clinical guidance available for #NSCLC during the current #drugshortages #lcsm Bookmark https://t.co/mPWChjj3yy for the latest guidance and updates on the availability of cisplatin and carboplatin. https://t.co/E6NbIWAVl2
-
RT @ASCO: ‼️ New clinical guidance available for #NSCLC during the current #drugshortages #lcsm Bookmark https://t.co/mPWChjj3yy for the l…
-
-
Mashup Score: 9Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
‼️ New clinical guidance available for #mesothelioma during the current #drugshortages. Bookmark https://t.co/mPWChjj3yy for the latest guidance and updates on the availability of cisplatin and carboplatin https://t.co/KZwTXh6ldX
-
-
Mashup Score: 8ASCO Awarded $11M to Study Oral Drug Dosing Strategies in Older Adults with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors - 1 year(s) ago
ALEXANDRIA, Va. — The American Society of Clinical Oncology (ASCO) has been awarded $11 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) to study dosing strategies of oral CDK4/6 inhibitors in older adults living with metastatic breast cancer. The study aims to address a critical evidence gap in the treatment of this disease: dose optimization and…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
Incredibly excited for this opportunity with support from @PCORI to study how we can help older patients with metastatic breast cancer better tolerate therapy w/ CDK4/6 inhibitors, & stay on treatment longer. @ASCO @DrDawnHershman @elmayermd @LGM_Biostats https://t.co/oGe5Fs9yQI https://t.co/Iz8pN9ZJgZ
-
-
Mashup Score: 15ASCO Awarded $11M to Study Oral Drug Dosing Strategies in Older Adults with Metastatic Breast Cancer Receiving CDK4/6 Inhibitors - 1 year(s) ago
ALEXANDRIA, Va. — The American Society of Clinical Oncology (ASCO) has been awarded $11 million in research funding by the Patient-Centered Outcomes Research Institute (PCORI) to study dosing strategies of oral CDK4/6 inhibitors in older adults living with metastatic breast cancer. The study aims to address a critical evidence gap in the treatment of this disease: dose optimization and…
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
We’re pleased to announce ASCO has been awarded $11M of @PCORI research funding to study CDK4/6 inhibitors dosing in older adults w metastatic breast cancer. Led by our CMO @jrgralow, the aim is to improve outcomes & fill a real-world evidence gap. More: https://t.co/iNfEyf3G1G https://t.co/7l1ngnLaCA
-
-
Mashup Score: 4Supportive Care and Treatment Related Issues - 1 year(s) ago
Supportive Care and Treatment Related Issues
Source: ASCOCategories: Latest Headlines, Partners & KOLsTweet-
Now available: guideline update on practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: https://t.co/bg543PSobc #GeriOnc #SuppOnc https://t.co/xXLvx6ed95
-
-
Mashup Score: 1Drug Shortages - 1 year(s) ago
ASCO Resources Related to Drug Shortages Please see @ASCO on Twitter for the most rapid updates on the availability of cisplatin and carboplatin. The medical community is currently experiencing ongoing, and in some cases, worsening shortages of critical drugs. Key information is provided below. If you have comments, concerns, suggestions for best practices, etc. pertaining to drug shortage,…
Source: ASCOCategories: Hem/Oncs, Latest HeadlinesTweet-
Recent updates to both “drug availability” and “clinical guidance”’ sections of the @ASCO drug shortages web page - https://t.co/vrCgE2Limn https://t.co/K7jEvAtwTm
-
JUST IN: The November @ASCO #ASCOPlenarySeries => 2 NEW #GI cancers Clinical trials! NOVEMBER 7th 3pm EST (FREE!): Link: https://t.co/WIHoq1N3vM Because...."Science can't (and shouldn't) wait"! @SoniSmithMD @SalemGIOncDoc @DrMMurphy @MLJohnsonMD2 @DannyGrayson913 @ASCOPres… https://t.co/4BqAemjdTM https://t.co/fpo4wjSoLv